Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials

Product News   May 22, 2013

 
Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Product News

Owlstone Medical and Cancer Research UK begin trial to improve the speed of detection and diagnosis of multiple cancer types.

READ MORE

Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News

Horizon announces completion of exclusive license, broadening the companies gene editing capabilities.

READ MORE

Arcinova Use FlowSyn for Efficient Scale-Up of Challenging Batch Processes

Product News

Arcinova has invested in a FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE